Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus
- PMID: 3115332
Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus
Abstract
We established an interleukin 2 (IL-2)-dependent human T cell line, Kit 225, from a patient with T cell chronic lymphocytic leukemia (T-CLL) with OKT3+, -T4+, -T8- phenotype. Southern blot analysis showed that Kit 225 is not infected with human T cell leukemia/lymphoma virus (HTLV) type I or II, and is probably derived from the major clone in the fresh leukemic cells. Kit 225 cells express a large amount of IL 2 receptors constitutively and their growth is absolutely dependent on IL 2. No other stimuli, such as lectins or antigens, are required for maintaining the responsiveness to IL 2. As abnormal IL 2 receptor expression was also seen originally in the fresh leukemic cells, the establishment of this cell line with IL 2 suggests that IL 2-mediated T cell proliferation is involved in the leukemogenesis of some cases of HTLV-negative T-CLL.
Similar articles
-
Expression of interleukin-2 receptor on T cell chronic lymphocytic leukemia cells and their response to interleukin-2.Blood. 1986 Feb;67(2):316-21. Blood. 1986. PMID: 3080037
-
Novel interleukin-2 dependent T-cell line derived from adult T-cell leukemia not associated with human T-cell leukemia virus type I.Jpn J Cancer Res. 1993 Apr;84(4):371-8. doi: 10.1111/j.1349-7006.1993.tb00146.x. Jpn J Cancer Res. 1993. PMID: 8390425 Free PMC article.
-
Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2--I. Retention of morphology, phenotype and selective cytotoxic properties in long term culture.Leuk Res. 1984;8(1):1-14. doi: 10.1016/0145-2126(84)90027-4. Leuk Res. 1984. PMID: 6321859
-
Malignant B-cells have receptors for and respond to interleukin-2.Med Oncol Tumor Pharmacother. 1986;3(3-4):255-63. doi: 10.1007/BF02935002. Med Oncol Tumor Pharmacother. 1986. PMID: 3100885 Review.
-
Growth of human T lymphocytes: an analysis of interleukin 2 and its cellular receptor.Prog Hematol. 1986;14:283-301. Prog Hematol. 1986. PMID: 2418464 Review. No abstract available.
Cited by
-
Induction of Cell Death in Growing Human T-Cells and Cell Survival in Resting Cells in Response to the Human T-Cell Leukemia Virus Type 1 Tax.PLoS One. 2016 Feb 1;11(2):e0148217. doi: 10.1371/journal.pone.0148217. eCollection 2016. PLoS One. 2016. PMID: 26829041 Free PMC article.
-
SILAC-based quantification of changes in protein tyrosine phosphorylation induced by Interleukin-2 (IL-2) and IL-15 in T-lymphocytes.Data Brief. 2015 Aug 22;5:53-8. doi: 10.1016/j.dib.2015.08.007. eCollection 2015 Dec. Data Brief. 2015. PMID: 26425665 Free PMC article.
-
LY294002 and rapamycin co-operate to inhibit T-cell proliferation.Br J Pharmacol. 2005 Mar;144(6):791-800. doi: 10.1038/sj.bjp.0706061. Br J Pharmacol. 2005. PMID: 15778701 Free PMC article.
-
OX40 signaling renders adult T-cell leukemia cells resistant to Fas-induced apoptosis.Int J Hematol. 2002 Oct;76(3):260-6. doi: 10.1007/BF02982796. Int J Hematol. 2002. PMID: 12416737
-
Epidermal growth factor receptor controls glycogen phosphorylase in T cells through small GTPases of the RAS family.J Biol Chem. 2019 Mar 22;294(12):4345-4358. doi: 10.1074/jbc.RA118.005997. Epub 2019 Jan 15. J Biol Chem. 2019. PMID: 30647127 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials